Search for: "GLAXOSMITHKLINE"
Results 41 - 60
of 1,808
Sort by Relevance
|
Sort by Date
7 Oct 2022, 11:15 am
GlaxoSmithKline; Micron announces plans to invest up to $100 billion over the next 20 years in constructing a computer chip manufacturing campus in a suburb of Syracuse, NY; Amgen files a supplemental brief with the U.S. [read post]
7 Oct 2022, 11:15 am
GlaxoSmithKline; Micron announces plans to invest up to $100 billion over the next 20 years in constructing a computer chip manufacturing campus in a suburb of Syracuse, NY; Amgen files a supplemental brief with the U.S. [read post]
3 Oct 2022, 4:56 pm
GlaxoSmithKline, involving liability for generic-drug manufacturers for labels that carve out patented uses found in the brand drug’s labeling. [read post]
28 Sep 2022, 11:54 am
Glaxosmithkline, Inc. [read post]
26 Sep 2022, 4:49 am
GlaxoSmithKline LLC, No. 22-37 This case delves deeply into the patent-FDA overlap and involves an increasingly common situation “skinny label” situation. [read post]
9 Sep 2022, 9:15 am
This week in Other Barks & Bites: former Federal Circuit Chief Judge Randall Rader urges inventors to pursue changes to flawed Federal Circuit case law; Federal Circuit Chief Judge Kimberly Moore opines that the patent dispute between Apple and VirnetX may never end during oral arguments; Tesla seeks relief from Texas property taxes to build the first lithium refining plant in North America; Teva files a reply brief with the Supreme Court asking the nation’s highest court to review the… [read post]
9 Sep 2022, 9:15 am
This week in Other Barks & Bites: former Federal Circuit Chief Judge Randall Rader urges inventors to pursue changes to flawed Federal Circuit case law; Federal Circuit Chief Judge Kimberly Moore opines that the patent dispute between Apple and VirnetX may never end during oral arguments; Tesla seeks relief from Texas property taxes to build the first lithium refining plant in North America; Teva files a reply brief with the Supreme Court asking the nation’s highest court to review the… [read post]
25 Aug 2022, 2:54 am
However, it is important to know that you must have developed the disease within 20 years of your last dose to become eligible to file a claim with the manufacturer, GlaxoSmithKline. [read post]
24 Aug 2022, 4:15 am
On August 19, British brand name pharmaceutical firm GlaxoSmithKline (GSK) filed a brief with the U.S. [read post]
24 Aug 2022, 4:15 am
On August 19, British brand name pharmaceutical firm GlaxoSmithKline (GSK) filed a brief with the U.S. [read post]
29 Jul 2022, 6:11 pm
GlaxoSmithKline, LLC 22-37Issue: Whether a generic drug manufacturer’s FDA-approved label that carves out all of the language the brand manufacturer has identified as covering its patented uses can be held liable on a theory that its label still intentionally encourages infringement of those carved-out uses. [read post]
19 Jul 2022, 2:40 pm
In an earlier case, beginning in 2015, global pharmaceutical giant GlaxoSmithKline faced hundreds of lawsuits after women who had taken Zofran (ondansetron) gave birth to infants with a host of complications, including cleft palate, skull deformities, and heart defects. [read post]
17 Jul 2022, 5:00 am
GlaxoSmithKline LLC, SCT Docket No. 22-37 (2022). [read post]
6 Jun 2022, 3:53 am
Tesaro was bought by GlaxoSmithKline, and Dr. [read post]
6 May 2022, 8:10 am
Cir. 2021), en banc denied at GlaxoSmithKline LLC v. [read post]
15 Apr 2022, 6:11 am
GlaxoSmithKline recalled its over-the-counter acid reflux medication Zantac in 2020, and Sandoz Inc. recalled its muscle spasm medication due to high nitrosamine levels the same day Pfizer announced its recall of Accuretic and its generic alternatives. [read post]
15 Apr 2022, 6:11 am
GlaxoSmithKline recalled its over-the-counter acid reflux medication Zantac in 2020, and Sandoz Inc. recalled its muscle spasm medication due to high nitrosamine levels the same day Pfizer announced its recall of Accuretic and its generic alternatives. [read post]
15 Apr 2022, 6:11 am
GlaxoSmithKline recalled its over-the-counter acid reflux medication Zantac in 2020, and Sandoz Inc. recalled its muscle spasm medication due to high nitrosamine levels the same day Pfizer announced its recall of Accuretic and its generic alternatives. [read post]
14 Apr 2022, 8:30 am
Attorney Hitchings was joined on the panel by Cheryl Meads, GlaxoSmithKline whistleblower and Taxpayers Against Fraud Board Member; Katie Lawler, U.S. [read post]
10 Apr 2022, 12:58 pm
Readers might find it interesting to compare Judge Prost’s opinion in this case with her dissent in the Federal Circuit’s recent “skinny label” decision, Glaxosmithkline v. [read post]
